Report: AstraZeneca Might Bid On Juno Therapeutics

By: via Benzinga
Juno Therapeutics Inc(NASDAQ: JUNO) gained about 14 percent on Tuesday after AstraZeneca plc (ADR) (NYSE: AZN) reportedly told ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.